Hans Hull, Chief Business Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 19,572 shares at $17.23 ($337K) on 2024-01-17, disclosed to the SEC on 2024-01-19.
Scheduled sale ($337k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.23 | 9,786 | $169K | 50.0% |
| 2 | $17.23 | 9,786 | $169K | 50.0% |
| Total | $17.23 avg | 19,572 | $337K | 100% |
| Filing → |
| PLRX | SELL | 2023-08-07 | $1.1M | — | Filing → |
| PLRX | SELL | 2023-07-19 | $646K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $479K | — | Filing → |